Literature DB >> 6967101

Measurement of canine von Willebrand factor using ristocetin and Polybrene. Diagnosis of canine von Willebrand's disease.

T K Rosborough, G S Johnson, R E Benson, W R Swaim, W J Dodds.   

Abstract

Dogs with VWD provide useful models for the study of the factor VIII complex. However, the study of canine VIIIR:WF has been hampered by the lack of a routine plasma assay for canine RCF, an activity that is usually used as a measure of VIIIR:WF. This study shows that canine plasma can be assayed for RCF with a macroscopic tilt-tube method using formalin-fixed human platelets, ristocetin, and extra canine albumin (5.0 mg/ml) to prevent plasma precipitation. An assay was also developed for canine plasma PBCF, an activity that is closely related to RCF. In 45 normal canine plasmas, VIII:C was not correlated with RCF, PBCF, or VIIIR:AG. However, RCF, PBCF, and VIIIR:AG were well correlated with each other. In 26 canine VWD plasmas, VIII:C was frequently normal, whereas VIIIR:AG, RCF, and PBCF were almost always deficient. The patterns of VIIIR:AG, RCF, and PBCF deficiencies in the canine VWD plasmas suggested that some canine breeds have a "classic" form of VWD whereas other breeds have "variant" forms of disease.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6967101

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


  3 in total

1.  Desmopressin enhances the binding of plasma von Willebrand factor to collagen in plasmas from normal dogs and dogs with type I von Willebrand's disease.

Authors:  I B Johnstone
Journal:  Can Vet J       Date:  1999-09       Impact factor: 1.008

2.  The effects of desmopressin on plasma factor VIII/von Willebrand factor activity in dogs with von Willebrand's disease.

Authors:  I B Johnstone; S Crane
Journal:  Can J Vet Res       Date:  1987-04       Impact factor: 1.310

3.  Von Willebrand's disease in two families of Doberman Pinschers.

Authors:  I B Johnstone; S Crane
Journal:  Can Vet J       Date:  1981-08       Impact factor: 1.008

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.